SUBSCRIBE
SUBSCRIBE

Kronos Bio

NEWS
Business
Belldegrun’s Third Fund Continues “Bold Investment Strategy” with $825 Million
Vida Ventures III will approach investments the same way its first two funds do, identifying and investing in what they believe to be transformative biomedical innovative companies.
June 24, 2021
 · 
3 min read
 · 
Mark Terry
Business
BioSpace Movers & Shakers, Aug. 21
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
August 20, 2020
 · 
4 min read
 · 
Alex Keown
Business
BioSpace Movers & Shakers, July 24
Biopharma and life sciences companies strengthen their leadership teams and board with these Movers & Shakers.
July 23, 2020
 · 
8 min read
 · 
Alex Keown
Business
BioSpace Movers & Shakers, July 10
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
July 9, 2020
 · 
7 min read
 · 
Alex Keown
Business
Top Life Sciences Startups to Watch in 2020
BioSpace is proud to present its NextGen Bio “Class of 2020,” a list of up-and-coming life science companies in North America that launched no earlier than mid-2018.
January 3, 2020
 · 
13 min read
 · 
Mark Terry
Business
BioSpace Movers & Shakers, Nov. 22
Pharma and biotech companies strengthen their leadership teams and boards with this week’s appointments.
November 21, 2019
 · 
5 min read
 · 
Alex Keown
AWARDS
  • NextGen Class of 2020
JOBS
IN THE PRESS
Press Releases
Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors
October 24, 2024
 · 
5 min read
Press Releases
Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors
October 9, 2024
 · 
4 min read
Press Releases
Kronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren’s Disease
October 8, 2024
 · 
7 min read
Press Releases
Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy
September 26, 2024
 · 
5 min read
Press Releases
Kronos Bio Highlights Data at AACR Ovarian Cancer Research Symposium that Supports Clinical Evaluation of Istisociclib in Advanced Ovarian Cancer
September 23, 2024
 · 
3 min read
Press Releases
Kronos Bio Announces Participation in Medical and Investor Conferences in September 2024
September 4, 2024
 · 
2 min read
Press Releases
Kronos Bio Reports Second Quarter 2024 Financial Results and Pipeline Update
August 9, 2024
 · 
8 min read
Drug Development
Kronos Bio Announces First Patient Dosed with KB-0742 in an Expansion Cohort Focused on Platinum-Resistant High-Grade Serous Ovarian Cancer
July 23, 2024
 · 
5 min read
Business
Kronos Bio Names Marc Besman, Ph.D., as Senior Vice President of Regulatory Affairs and Clinical Quality Assurance
June 6, 2023
 · 
2 min read
Business
Kronos Bio Reports Recent Business Progress and Second Quarter 2021 Financial Results
August 12, 2021
 · 
8 min read
Load More